Regenstrief Institute names new president and CEO

2023-02-08
高管变更
Indiana University School of Medicine this week announced that Rachel E. Patzer, an expert in epidemiology and health services research, has been appointed to be president and chief executive officer of the school-affiliated Regenstrief Institute. WHY IT MATTERS Patzer, who holds degrees including a masters in public health and a doctorate in epidemiology, will begin the new role on May 1. She currently works at Emory University School of Medicine, where she serves as the founding director of its Health Services Research Center and is a tenured professor there in the school's department of surgery. She founded the Health Services Research Center at Emory five years ago with the aim of opportunities for closer connections and collaboration between methodologists and clinical researchers. Patzer has long been focused on health equity and has proven herself a leader in data-driven efforts to increase patient access, improve delivery and boost health outcomes, say Regenstrief officials. "Over the course of her career, Dr. Patzer's work in using data to expose inequities and inefficiencies in health systems aligns perfectly with the important work being done by our world-class researchers at the Regenstrief Institute," said Dr. Jay L. Hess, dean of the IU School of Medicine, in a statement. "It is a critical time in our community for health care research, and I am confident that Dr. Patzer is the transformative leader needed to take the Regenstrief Institute into the future." THE LARGER TREND Regenstrief is a leader dedicated to improving health and healthcare through innovations and research in biomedical informatics. Among just some of its recent innovative data research: a framework announced in January to to assess the accuracy of patient matching algorithms ; HIE-trained AI models to forecast individual COVID-19 hospitalization risk ; a surveillance system using EHR data to track long COVID and, eventually, support nationwide population health studies. The institute has also recently led research on the "double-edged sword" of clinical texting , worked closely with the Indiana Health Information Exchange , collaborated with University of Utah Health on AI models to develop personalized Type 2 diabetes care and more. "Data is critical, but it won't improve health on its own," said Tatiana Foroud, executive associate dean for research affairs at IU School of Medicine, and vice chair of the Regenstrief board of directors. "Dr. Patzer's experience in establishing the connection between methodology and clinical practice will be key to making a meaningful impact on the health of people in our state, our nation and around the world." ON THE RECORD "I am excited to work with the internationally renowned Regenstrief investigators in biomedical informatics, aging, and health services research, who are leading the way in using data – from an ever-increasing number and types of sources to improve health," said Patzer in a statement. "The Institute has contributed so significantly to such areas as electronic health records, health information exchange, health outcomes research, collaborative care, addressing the inclusion of neglected populations into research and many other areas." she added. Email the writer: mike.miliard@himssmedia.com Healthcare IT News is a HIMSS publication.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。